{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.500","meta":{"versionId":"11","lastUpdated":"2018-07-21T01:09:36.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.500","version":"20180721","name":"Cytogenetic Testing Performed","status":"active","date":"2018-07-21T01:00:04-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"3155F","display":"Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM)"},{"code":"88271","display":"Molecular cytogenetics; DNA probe, each (eg, FISH)"},{"code":"88272","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)"},{"code":"88273","display":"Molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)"},{"code":"88274","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cells"},{"code":"88275","display":"Molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cells"},{"code":"88291","display":"Cytogenetics and molecular cytogenetics, interpretation and report"},{"code":"88299","display":"Unlisted cytogenetic study"}]}]}}